Axsome Therapeutics (AXSM) is up 17.5%, or $26.03 to $174.82.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXSM:
- Axsome Advances AXS-12 Toward NDA Filing for Narcolepsy
- Axsome Therapeutics announces FDA acceptance, priority review of AXS-05 sNDA
- Axsome Therapeutics says AXS-12 NDA submission on track for January
- Strategic Acquisition and Pipeline Expansion Drive Buy Rating for Axsome Therapeutics
- Avenue Therapeutics announces Baergic Bio acquisition by Axsome